T cells localized to the androgen-deprived prostate are TH1 and TH17 biased

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Update on Prostate Cancer Vaccines

(2011) Charles G. Drake   CANCER JOURNAL

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

FLIP-ping out: Death receptor signaling in the prostate

(2010) Kent L. Nastiuk et al.   CANCER BIOLOGY & THERAPY

Immune Signatures Predict Prognosis in Localized Cancer

(2010) David S Hsu et al.   CANCER INVESTIGATION

In situ Vaccination Combined with Androgen Ablation and Regulatory T-Cell Depletion Reduces Castration-Resistant Tumor Burden in Prostate-Specific Pten Knockout Mice

(2010) Elizabeth J. Akins et al.   CANCER RESEARCH

Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients

(2010) Carlo Sorrentino et al.   CLINICAL CANCER RESEARCH

Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses

(2010) Matthew D. Morse et al.   HUMAN IMMUNOLOGY

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

(2010) Massimo Ammirante et al.   NATURE

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lymphocytes in cancer development: Polarization towards pro-tumor immunity

(2009) Brian Ruffell et al.   CYTOKINE & GROWTH FACTOR REVIEWS

II. Stromal and Epithelial Cells from Rat Ventral Prostate during Androgen Deprivation and Estrogen Treatment — Regulation of Transcription

(2009) M. Bacher et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Prostate autoimmunity: from experimental models to clinical counterparts

(2009) Giuseppe Penna et al.   Expert Review of Clinical Immunology

Pretreatment frequency of circulating IL-17+CD4+T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients

(2009) Evelyna Derhovanessian et al.   INTERNATIONAL JOURNAL OF CANCER

Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients

(2009) Philippe O. Gannon et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization

(2009) Yi T. Koh et al.   PROSTATE

CCL25 increases thymopoiesis after androgen withdrawal

(2008) K. M. Williams et al.   BLOOD

Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing

(2008) K. S. Sfanos et al.   CLINICAL CANCER RESEARCH